近日公開 Coming Soon

医薬品臨床応用データセット

Real world drug record, prescription analysis, frequency and treatment data, rational use of drug AI to support decision-making.

薬効記録
处方サイズ:
期間
EMR/RWD
ソース
近日公開
状态

データセット概要

医薬品臨床応用データセットChangsha Langhui Information Technology Co., Ltd.Based on the database of the real world applications of medicines built by the DataAssetsAPI platform, a collection of real world drug records from cooperative medical institutions and prescription systems covers core dimensions such as prescription analysis, frequency of use, treatment process data, joint drug use models, and is carefully dissensitized to support rational drug use AI decision-making, drug use research (DUR) and clinical pharmaceutical analysis.

データセット名医薬品臨床応用データセット
データ種別Real World Drug Record + Prescription Analysis Data + Structured JSON
核心内容Common name of drugs, date of prescription, amount of use, route of delivery, frequency of use, length of treatment, joint use, diagnosis (ICD code), prescription unit, age/sex of patient (dissensitization)
ソースデータEMR, Prescription Management System
活用シーンDrug Use AI Decision-Making, Drug Use Research (DUR), Prescription Behaviour Analysis, Joint Drug Model Excavation, Integrated Drug Clinical Evaluation
フォーマット 出力Structured JSON + CSV 导出 + API 接口
状态近日公開

核心データ次元

Data sets are organized using a full chain of drug clinical application, covering the complete data chain from prescription to drug assessment.

サイズ:大类フィールド数代表的なフィールド价值层级
药品标识8Drugs generic, trade/brand, approval number, ATC code, formulation, specifications, manufacturers, classification of drugs基础标识
处方信息12Prescription date, prescription number, type of prescription (outpatient/hospital/emergency), prescription office, specialist prescription physician, usage, route of delivery, single dose, frequency of delivery, number of days of treatment, total prescription dose, state of prescription中心次元
诊断关联8Main diagnosis (ICD-11), secondary diagnosis, type of diagnosis, drug use and diagnosis match, drug overstated, adaptive deviation, clinical path matching, consistency of guidelines中心次元
联合用药10List of joint medicines, DDI risk class, DDI mechanism classification, joint drug rationality rating, anti-promotive marking, polypharmaceutical rating, antibacterial drug combination marking, Chinese-Western drug combination高级分析
疗程管理6Actual treatment days, standard course comparison, completion of treatment, stop-to-do mark, cause classification, long-term drug mark (30 days ⁇ 90 days ⁇ 180 days)高级分析
患者画像8Age of patients (dissensitization group), sex, type of consultation, method of payment, summary of disease history, allergies, liver and kidney function (eGFR/child-Pugh grade), special population markers (pregnancy/lactation/child/old age)上下文信息
メタデータ6Date of data entry, source agency (dissensitization), data quality rating, completeness rating, dissensitisation, version number品質管理

AI活用シーン

A. Decision-making system for rational use of medicines

Training in the rational use of the AAI model based on real world prescription data, which provides for prescription smart auditing, over-state drug identification and individualization of drug recommendations to the drug programme.

Drug Use Research (DUR)

Multidimensional data analysis, such as prescription frequency, treatment process, joint drug use model, supports drug use evaluation, drug use trend analysis and rational drug use policy development.

Analysis and optimization of prescription behaviour

Analysis of prescription behaviour patterns at the section/speciality level, identification of prescription anomalies and unreasonable drug signals, support for clinical path optimization and prescription point evaluation.

Integrated clinical evaluation of pharmaceuticals

A comprehensive clinical evaluation of the actual world drug data supporting drugs, covering the assessment of effectiveness, safety, economy and suitability in multiple dimensions.

よくあるご質問

When will the dataset go live?
The clinical application data set is currently in the data integration and quality review phase and is expected to be officially available in the near future. The data set will cover the true world drug records of several cooperative medical institutions, and the data are being finally cleaned and validated through the dissensitisation process and quality rating system.
What are the sections and areas of treatment covered by the data?
The data sets are intended to cover prescriptions for major clinical units, such as the internal medicine, surgery, paediatrics, gynaecology and obstetrics, emergency care, oncology, cardiovascular, endocrine, respiratory, and infectious.

カスタマイズしたデータソリューションが必要ですか?

Changsha Langhui Information Technology Co., Ltd. The DataAsetsAPI platform is dedicated to providing high-quality, compliant data assets to AI enterprises and scientific institutions.

データサンプルプレビュー・カスタマイズデータソリューション・ProSupport